Evidence map›Paper›PMID 23128226›Full record

ArticleNature2012

An integrated map of genetic variation from 1,092 human genomes.

1000 Genomes Project Consortium, Goncalo R Abecasis, Adam Auton, Lisa D Brooks, Mark A DePristo, Richard M Durbin, Robert E Handsaker, Hyun Min Kang, Gabor T Marth, Gil A McVean

Abstract read
In one paragraph

Article in Nature, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4,700 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4,700citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4,700 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Article
  11. Article
  12. Multi-Omics Genome-Wide to Explore the Formation and Development Targets for Intracranial Aneurysms.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4,640 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

1000 Genomes Project Consortium
Goncalo R Abecasis
Adam Auton
Lisa D Brooks
Mark A DePristo
Richard M Durbin
Robert E Handsaker
Hyun Min Kang
Gabor T Marth
Gil A McVean

Funding

Large Scale Sequencing and Analysis of GenomesU54HG003067 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GABRIEL, STACEY, LANDER, ERIC S · 2004 to 2015
$568.6M
Large Scale Genome SequencingU54HG003079 · NHGRI · WASHINGTON UNIVERSITY · PI DUTCHER, SUSAN K · 2004 to 2016
$445.7M
The Human Genome Sequencing CenterU54HG003273 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI GIBBS, RICHARD A · 2004 to 2015
$341.3M
Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Understanding Asthma EndotypesU19AI077439 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI David J Erle · 2008 to 2026
$41.1M
UCSC Center for Genomic Science, and Minority Outreach ProgramP41HG002371 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI HAUSSLER, DAVID H · 2001 to 2011
$34.8M
VIRAL SEQUENCES IN PEDIATRIC HIV INFECTION IN PRG12RR003050 · NCRR · PONCE SCHOOL OF MEDICINE · PI ARMSTRONG, RAUL A · 1985 to 2011
$28.1M
POSTDOCTORAL TRAINING IN MEDICAL INFORMATION SCIENCEST15LM007033 · NLM · STANFORD UNIVERSITY · PI SYLVIA KATINA PLEVRITIS · 1985 to 2026
$25.5M
MEDICAL INFORMATICS RESEARCH TRAINING AT YALET15LM007056 · NLM · YALE UNIVERSITY · PI Mark Bender Gerstein, LUCILA OHNO-MACHADO · 1987 to 2026
$22.2M
VIRAL SEQUENCES IN PEDIATRIC HIV INFECTION IN PRG12MD007579 · NIMHD · PONCE SCHOOL OF MEDICINE · PI YAMAMURA, YASUHIRO · 2012 to 2018
$15.9M
Biotechnology and Biological Sciences Research Council BB/I021213/1Biotechnology and Biological Sciences Research Council BB/I02593X/1British Heart Foundation RG/09/012/28096British Heart Foundation RG/09/12/28096Howard Hughes Medical InstituteMedical Research Council G0701805Medical Research Council G0801823Medical Research Council G0900747Medical Research Council G0900747(91070)NCATS NIH HHS UL1 TR000124NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA166661NCI NIH HHS R01CA166661NCRR NIH HHS G12 RR003050NCRR NIH HHS UL1 RR024131NCRR NIH HHS UL1RR024131NHGRI NIH HHS P01 HG004120NHGRI NIH HHS P01HG4120NHGRI NIH HHS P41 HG002371NHGRI NIH HHS P41 HG004221NHGRI NIH HHS P41HG2371NHGRI NIH HHS P41HG4221NHGRI NIH HHS R01 HG002898NHGRI NIH HHS R01 HG003698NHGRI NIH HHS R01 HG004719NHGRI NIH HHS R01 HG004960NHGRI NIH HHS R01 HG005701NHGRI NIH HHS R01 HG007022NHGRI NIH HHS R01HG2898NHGRI NIH HHS R01HG3698NHGRI NIH HHS R01HG4719NHGRI NIH HHS R01HG4960NHGRI NIH HHS R01HG5701NHGRI NIH HHS RC2 HG005552NHGRI NIH HHS RC2 HG005581NHGRI NIH HHS RC2HG5552NHGRI NIH HHS RC2HG5581NHGRI NIH HHS U01 HG005208NHGRI NIH HHS U01 HG005209NHGRI NIH HHS U01 HG005211NHGRI NIH HHS U01 HG005214NHGRI NIH HHS U01 HG005715NHGRI NIH HHS U01 HG005725NHGRI NIH HHS U01 HG005728NHGRI NIH HHS U01 HG006513NHGRI NIH HHS U01 HG006569NHGRI NIH HHS U01HG5208NHGRI NIH HHS U01HG5209NHGRI NIH HHS U01HG5211NHGRI NIH HHS U01HG5214NHGRI NIH HHS U01HG5715NHGRI NIH HHS U01HG5725NHGRI NIH HHS U01HG5728NHGRI NIH HHS U01HG6513NHGRI NIH HHS U01HG6569NHGRI NIH HHS U41 HG004568NHGRI NIH HHS U41HG4568NHGRI NIH HHS U54 HG003067NHGRI NIH HHS U54 HG003079NHGRI NIH HHS U54 HG003273NHGRI NIH HHS U54HG3067NHGRI NIH HHS U54HG3079NHGRI NIH HHS U54HG3273NHLBI NIH HHS HHSN268201100040CNHLBI NIH HHS HL078885NHLBI NIH HHS R01 HL078885NHLBI NIH HHS R01 HL088133NHLBI NIH HHS R01 HL095045NHLBI NIH HHS R01HL95045NHLBI NIH HHS RC2 HL102925NHLBI NIH HHS RC2HL102925NHLBI NIH HHS T32 HL094284NHLBI NIH HHS T32HL94284NIAID NIH HHS AI077439NIAID NIH HHS AI2009061NIAID NIH HHS U19 AI077439NIEHS NIH HHS ES015794NIEHS NIH HHS R01 ES015794NIGMS NIH HHS R01 GM059290NIGMS NIH HHS R01GM59290NIGMS NIH HHS T32 GM007748NIGMS NIH HHS T32 GM008283NIGMS NIH HHS T32GM7748NIGMS NIH HHS T32GM8283NIH HHS DP2 OD006514NIH HHS DP2OD6514NIMHD NIH HHS G12 MD007579NIMHD NIH HHS P20 MD006899NIMH NIH HHS R01 MH084698NIMH NIH HHS R01MH84698NLM NIH HHS T15 LM007033NLM NIH HHS T15 LM007056NLM NIH HHS T15LM7033Wellcome Trust 085532Wellcome Trust 086084Wellcome Trust 090532Wellcome Trust 095908Wellcome Trust 096599Wellcome Trust WT085475/Z/08/ZWellcome Trust WT085532AIAWellcome Trust WT086084/Z/08/ZWellcome Trust WT089250/Z/09/ZWellcome Trust WT090532/Z/09/ZWellcome Trust WT095552/Z/11/ZWellcome Trust WT098051
6 · The paper itself

Abstract

By characterizing the geographic and functional spectrum of human genetic variation, the 1000 Genomes Project aims to build a resource to help to understand the genetic contribution to disease. Here we describe the genomes of 1,092 individuals from 14 populations, constructed using a combination of low-coverage whole-genome and exome sequencing. By developing methods to integrate information across several algorithms and diverse data sources, we provide a validated haplotype map of 38 million single nucleotide polymorphisms, 1.4 million short insertions and deletions, and more than 14,000 larger deletions. We show that individuals from different populations carry different profiles of rare and common variants, and that low-frequency variants show substantial geographic differentiation, which is further increased by the action of purifying selection. We show that evolutionary conservation and coding consequence are key determinants of the strength of purifying selection, that rare-variant load varies substantially across biological pathways, and that each individual contains hundreds of rare non-coding variants at conserved sites, such as motif-disrupting changes in transcription-factor-binding sites. This resource, which captures up to 98% of accessible single nucleotide polymorphisms at a frequency of 1% in related populations, enables analysis of common and low-frequency variants in individuals from diverse, including admixed, populations.

Indexed as

Genetics, PopulationGenomicsAllelesBinding SitesConserved SequenceEvolution, MolecularGenetics, MedicalGenetic VariationGenome, HumanGenome-Wide Association StudyHaplotypesHumansNucleotide MotifsPolymorphism, Single NucleotideRacial GroupsSequence DeletionTranscription Factors

Identifiers

PMID23128226
PMCPMC3498066

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.